Diabetic Cardiomyopathies clinical trials

The registry lists 30 studies for Diabetic Cardiomyopathies across more than 10 countries. 9 are recruiting or about to start. 14 of them are mainly about Diabetic Cardiomyopathies (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-02.

Get an email when these change. Save the Diabetic Cardiomyopathies studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 12
Recruiting: 6
Status unknown: 5
Not yet recruiting: 2
Active, not recruiting: 2
Terminated: 1

Phase

Phase 2: 5
Phase 3: 2
Phase 1: 2
Phase 4: 1

Where

United States: 8
United Kingdom: 6
France: 6
Germany: 3
Egypt: 2
Italy: 2

Who runs them

University of Texas Southwestern Medical Center (3) · University of Roma La Sapienza (2) · Washington University School of Medicine (2) · University of Louisville (1) · Slagelse Hospital (1) · Centre Hospitalier Universitaire de Nice (1) · University Hospital, Strasbourg, France (1) · Applied Therapeutics, Inc. (1)

What is being tested here

Drugs under test in Diabetic Cardiomyopathies studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Phase 3	All
Caficrestat	1	1
Grapiprant	1	1
Dapagliflozin	0	1
Ninerafaxstat	0	1
Tadalafil	0	1
Fenofibrate	0	1
Trimetazidine	0	1
Perhexiline	0	1
Probiotic	0	1

Coming up

2phase 3 studies under way

4studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4, phase 3 first

Dec 2026Tailored Exercise Training Study Among Adults With HFpEF · Phase 3 · University of Texas Southwestern Medical Center
Dec 2026CMR in T2DM: The NSR Cohort · Slagelse Hospital
Sep 2027Polypill for Prevention of Cardiomyopathy · University of Texas Southwestern Medical Center
Oct 2027Soluble TREM-1 in Diabetes-Associated Cardiovascular Complications · Assiut University

Who these studies take

Of the 6 Diabetic Cardiomyopathies studies recruiting now, 3 (50%) set no upper age limit and 1 (17%) stop at 75 or younger. 1 (17%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (33%) take healthy volunteers.

Recruiting studies that take each age, of 6
Age	Women	Men
10	1 (17%)	1 (17%)
18	3 (50%)	3 (50%)
30	5 (83%)	5 (83%)
40	5 (83%)	5 (83%)
50	6 (100%)	6 (100%)
65	6 (100%)	6 (100%)
75	6 (100%)	6 (100%)
85	5 (83%)	5 (83%)

Across all 30 studies, recruiting or not: 33% stop at 75 or younger and 17% at 65; 7% take children; 0% are for women only and 0% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 14, 2026.

Newly registered1

Differentiating Heart Disease Between Adult-onset Autoimmune and Type 2 DiabetesNov 2, 2026NCT07911007

Studies

Recruiting first, then most recently updated. Showing 30 of 30. search them.